Verde Bio Holdings, Inc. (APHD) stock
APHDOTCCrude Petroleum & Natural GasFiscal year ends April 30
Financials through Q3 FY2024, quarter ended Jan 31, 2024Last filing: 10-Q on Mar 25, 2024
$1.27+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.36BP/E –Yield –
Verde Bio EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Verde Bio's EPS for the twelve months ending Apr 30, 2022 was $0.00. For fiscal 2022 it was $0.00. The highest annual figure on record is $0.00 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Apr 30, 2022 | $0.00 | – |
| FY2021 | Apr 30, 2021 | -$0.03 | – |
| FY2020 | Apr 30, 2020 | -$1.03 | – |
| FY2019 | Apr 30, 2019 | -$0.53 | – |
| FY2018 | Apr 30, 2018 | -$0.10 | – |
| FY2017 | Apr 30, 2017 | -$2.97 | – |
| FY2016 | Apr 30, 2016 | -$1.00 | – |
| FY2015 | Apr 30, 2015 | -$100.00 | – |
| FY2014 | Apr 30, 2014 | -$548.00 | – |
| FY2013 | Apr 30, 2013 | -$200.00 | – |
| FY2012 | Apr 30, 2012 | -$400.00 | – |
| FY2011 | Apr 30, 2011 | -$400.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | $0.00 | – |
| Q3 FY2023CQ4 2022 | Jan 31, 2023 | $0.00 | – |
| Q4 FY2022CQ1 2022 | Apr 30, 2022 | $0.00 | – |
| Q3 FY2022CQ4 2021 | Jan 31, 2022 | $0.00 | -100.0% |
| Q2 FY2022CQ3 2021 | Oct 31, 2021 | $0.00 | – |
| Q1 FY2022CQ2 2021 | Jul 31, 2021 | $0.00 | – |
| Q3 FY2021CQ4 2020 | Jan 31, 2021 | $0.00 | – |
| Q2 FY2021CQ3 2020 | Oct 31, 2020 | $0.01 | – |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | -$0.04 | – |
| Q3 FY2020CQ4 2019 | Jan 31, 2020 | -$0.22 | – |
| Q2 FY2020CQ3 2019 | Oct 31, 2019 | -$0.17 | – |
| Q1 FY2020CQ2 2019 | Jul 31, 2019 | -$0.36 | – |
| Q3 FY2019CQ4 2018 | Jan 31, 2019 | -$0.08 | – |
| Q2 FY2019CQ3 2018 | Oct 31, 2018 | -$0.10 | – |
| Q1 FY2019CQ2 2018 | Jul 31, 2018 | -$0.01 | – |
| Q3 FY2018CQ4 2017 | Jan 31, 2018 | -$0.01 | – |
| Q2 FY2018CQ3 2017 | Oct 31, 2017 | -$0.05 | – |
| Q1 FY2018CQ2 2017 | Jul 31, 2017 | -$0.03 | – |
| Q3 FY2017CQ4 2016 | Jan 31, 2017 | -$0.03 | – |
| Q2 FY2017CQ3 2016 | Oct 31, 2016 | -$0.77 | – |
| Q1 FY2017CQ2 2016 | Jul 31, 2016 | -$1.00 | – |
| Q3 FY2016CQ4 2015 | Jan 31, 2016 | -$4.00 | – |
| Q2 FY2016CQ3 2015 | Oct 31, 2015 | -$18.00 | – |
| Q1 FY2016CQ2 2015 | Jul 31, 2015 | $0.00 | – |
| Q3 FY2015CQ4 2014 | Jan 31, 2015 | -$27.00 | – |
| Q2 FY2015CQ3 2014 | Oct 31, 2014 | -$89.00 | – |
| Q1 FY2015CQ2 2014 | Jul 31, 2014 | -$67.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?